POTTS W, MANNING C, WAKELAND E. Mating patterns in seminaturalpopulations of mice influenced by MHC genotype[J]. Nature, 1991, 352:619-621. MASSAGUE J,BLAIN S, LO R. TGF-beta signaling in growth control,cancer,and heritable disorders[J]. Cell, 2000, 103:295-309. SIMPSON H, ROBSON S C, BULMER J N, et al. Transforming growth factor beta expression in human placenta and placental bed during early pregnancy[J]. Placenta, 2002, 23(1):44-58. ARCK P, HAGEN E, HILDEBRANDT M, et al. Pregnancy as a Model of controlled invasion might be attributed to the ratio of CD3/CD8 to CD56[J]. Am J Reprod Immunol, 2000, 44(1):1-8. MARTAL J, CHENE N, CAMOUS S, et al. Recent developments and potentialities for reducing embryo mortality in ruminants: the role of IFN-tau and other cytokines in early pregnancy[J]. Reprod, Fertil Dev, 1997, 9(3):355-380. CLARK D,COKER R. Transforming growth factor-beta(TGF-β1)[J]. Int J Bilchem Cell Bio, 1998, 30: 293-298. SELICK C, HOROWITZ G, GRATCH M, et al. Immunohistochemical localization of transforming growth factor-beta in human implantation sites[J]. J Clin Endocrinol Metab, 1994, 78:592-596. 夏红飞,郝艳红,彭景楩. 妊娠大鼠子宫和胎盘IL-1β表达及IFN-γ对其表达的影响[J].动物学报,2004,50(1):48-54. 刘美玲,彭景楩,孙泉红,等. 妊娠大鼠子宫和胎盘TGF-β1的表达及IFN-γ对其的影响[J].生物化学与生物物理进展,2005,3(5):413-420. SCHMIDT C, ORR H. Maternal/fetal interactions: the role of the MHC class I molecule HLA-G[J]. Crit Rev Immunol, 1993, 13(3-4):207-224. AUDUS K L, SOARES M J, HUNT J S. Characteristics of the fetal/maternal interface with potential usefulness in the development of future immunological and pharmacological strategies [J]. J Pharmacol Exp Ther, 2002, 301:402-409. KOYAMA E, SHIMO T, IWAMOTO M, et al. Development of stratum intermedium and its role as a Sonic hedgehog-signaling structure duing odontogenesis [J]. Dev Dyn, 2001, 222(2):178-191. HOLLING T M, VANDER STOEP N, QUINTEN E, et al. Activated human T cells accomplish MHC class Ⅱ expression through T cellspecific occupation of class Ⅱ transactivator promoter Ⅲ[J]. J Immunol, 2002, 168:763-770. PEARSON G, ROBINSON F, BEARS T, et al. Mitogen-activated protein(MAP)kinase pathways: Regulation and physiological functions[J]. Endocr Rev, 2001, 22(2):153-183. PRUDHOMME G J, PICCIRILLO C A. The inhibitory effector of transforming growth factorbeta-1 (TGF-β1) in autoimmune diseases[J]. J Autoimmun, 2000, 14(1):23-42. MASTERNAK K, PEYRAUD N, KRAWCZYK M, et al. Chromatin remodeling and extragenic transcription at the MHC class locus control region[J]. Nat Immunol, 2003, 4:132-137. SHOONER C, CARON P, FRECHETTE-FRIGON G, et al. TGF-beta expression during rat pregnancy and activity on decidual cell survival[J]. Reprod Biol Endocrinol, 2005, 3(10): 20-22. CHUNG I B, YELIAN F D, ZAHER F M, et al. Expression and regulation of vascular endothelial growth factor in a first trimester trophoblast cell line[J]. Placenta, 2000, 21(4):320-324. CROSS J, HEMBERGER M, LU Y, et al. Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta[J]. Mol Cell Endocrinol, 2002, 187:207-212. ADAMSON S L, LU Y, WHITELEY K J, et al. Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta[J]. Dev Biol, 2002, 250(2):358-373. LEE K, ITO K, HAYASHI R, et al. NF-{kappa}B and activator protein 1 response elements and the role of histone modifications in IL-1{beta}-induced TGF-{beta}1 gene transcription[J]. J Immunol, 2006, 176(1): 603-615. |